Literature DB >> 23011313

Iristectorigenin B isolated from Belamcanda chinensis is a liver X receptor modulator that increases ABCA1 and ABCG1 expression in macrophage RAW 264.7 cells.

Hee-jin Jun1, Minh-Hien Hoang, Jin Woo Lee, Jia Yaoyao, Ji-Hae Lee, Dong-Ho Lee, Hak-Ju Lee, Woo-Duck Seo, Bang Yeon Hwang, Sung-Joon Lee.   

Abstract

A novel liver X receptor (LXR) modulator, iristectorigenin B isolated from Belamcanda chinensis, stimulated the transcriptional activity of both LXR-α and LXR-β. In macrophages, iristectorigenin B suppressed cholesterol accumulation in a dose-dependent manner and induced the transcriptional activation of LXR-α/-β-responsive genes, ATP-binding cassette transporters A1 and G1. It did not induce hepatic lipid accumulation nor the expression of the lipogenesis genes sterol regulatory element-binding protein-1c, fatty acid synthase, and stearoyl-CoA desaturase-1. Iristectorigenin B thus is a dual-LXR agonist that regulates the expression of key genes in cholesterol homeostasis in macrophage cells without inducing hepatic lipid accumulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011313     DOI: 10.1007/s10529-012-1036-y

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  5 in total

Review 1.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

Review 2.  Nuclear receptors in the kidney during health and disease.

Authors:  Andrew E Libby; Bryce Jones; Isabel Lopez-Santiago; Emma Rowland; Moshe Levi
Journal:  Mol Aspects Med       Date:  2020-11-30

3.  Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson's disease therapy.

Authors:  Yue-Mi Chen; Shih-Ping Liu; Hsin-Lien Lin; Ming-Chia Chan; Yen-Chuan Chen; Yu-Ling Huang; Min-Chen Tsai; Ru-Huei Fu
Journal:  Biomedicine (Taipei)       Date:  2015-02-02

Review 4.  Ligands of Therapeutic Utility for the Liver X Receptors.

Authors:  Rajesh Komati; Dominick Spadoni; Shilong Zheng; Jayalakshmi Sridhar; Kevin E Riley; Guangdi Wang
Journal:  Molecules       Date:  2017-01-05       Impact factor: 4.411

Review 5.  Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Authors:  Jianglian She; Tanwei Gu; Xiaoyan Pang; Yonghong Liu; Lan Tang; Xuefeng Zhou
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.